Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like Challenging the management of drug-resistant tuberculosis – Authors’ reply September 3, 2020 Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients. November 25, 2005 Cardiac arrest telephone numbers. June 9, 1990 Pleural tuberculosis: an update. July 16, 2010 COVID-19 care in India: the course to self-reliance September 3, 2020
Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients. November 25, 2005